today announced that Ramy Farid, Ph.D., chief executive officer, will
present at the Jefferies 2019 Global Healthcare Conference on Thursday,
June 6, 2019 at 11:00 a.m. ET in New York, NY.
Schrödinger has a substantial and growing global business, licensing its
industry-leading computational platform to pharmaceutical,
biotechnology, chemical, and electronics companies to accelerate R&D in
both drug discovery and materials design. Schrödinger has built a robust
pipeline of therapeutic assets, held both internally and in
partnerships, and has co-founded leading biotech companies, including
Nimbus Therapeutics and Morphic Therapeutic. Schrödinger’s significant
and ongoing investment in basic research continues to drive advances in
its computational platform. Founded in 1990, Schrödinger has
approximately 400 employees in its New York City headquarters and around
the world. Visit schrodinger.com
for more information.